Yoshio Iwashima

4.2k total citations · 1 hit paper
50 papers, 1.6k citations indexed

About

Yoshio Iwashima is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yoshio Iwashima has authored 50 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Cardiology and Cardiovascular Medicine, 11 papers in Endocrinology, Diabetes and Metabolism and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yoshio Iwashima's work include Blood Pressure and Hypertension Studies (23 papers), Hormonal Regulation and Hypertension (9 papers) and Heart Failure Treatment and Management (8 papers). Yoshio Iwashima is often cited by papers focused on Blood Pressure and Hypertension Studies (23 papers), Hormonal Regulation and Hypertension (9 papers) and Heart Failure Treatment and Management (8 papers). Yoshio Iwashima collaborates with scholars based in Japan, United States and Israel. Yoshio Iwashima's co-authors include Yuhei Kawano, Takeshi Horio, Fumiki Yoshihara, Satoko Nakamura, Yoichi Takami, Takashi Inenaga, Hiromi Rakugi, Toshio Ogihara, Kei Kamide and Yoshihiro Kokubo and has published in prestigious journals such as PLoS ONE, Hypertension and European Heart Journal.

In The Last Decade

Yoshio Iwashima

46 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Hypoadiponectinemia Is an Independent Risk Factor for Hypertension

2004 514 citations Yoshio Iwashima, Tomohiro Katsuya et al. Hypertension profile →

Peers

Yoshio Iwashima

CCM

EPIDE

PRM

PHYSI

SURGE

Giuseppe Seminara Italy

Francesco Rapisarda Italy

Jayashri Aragam United States

Saverio Parlongo Italy

Erkan Ayhan Türkiye

Narat Srivali United States

Arthur Kerner Israel

Søren Galatius Denmark

Kyoung Im Cho South Korea

Alfredo Bardajı́ Spain

Giuseppe Seminara Italy

Yoshio Iwashima

1.1k ×1.2

CCM

537 ×1.1

EPIDE

302 ×0.8

PRM

304 ×1.1

PHYSI

291 ×1.1

SURGE

Citations per year, relative to Yoshio Iwashima Yoshio Iwashima (= 1×) peers Giuseppe Seminara

Countries citing papers authored by Yoshio Iwashima

Since Specialization

Citations

This map shows the geographic impact of Yoshio Iwashima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoshio Iwashima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoshio Iwashima more than expected).

Fields of papers citing papers by Yoshio Iwashima

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoshio Iwashima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoshio Iwashima. The network helps show where Yoshio Iwashima may publish in the future.

Co-authorship network of co-authors of Yoshio Iwashima

This figure shows the co-authorship network connecting the top 25 collaborators of Yoshio Iwashima. A scholar is included among the top collaborators of Yoshio Iwashima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoshio Iwashima. Yoshio Iwashima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Iwashima, Yoshio, et al.. (2024). Plasma renin activity as a marker for predicting the antihypertensive effect of switching to sacubitril/valsartan in treated hypertensive patients: Usefulness in daily clinical practice. Journal of Clinical Hypertension. 26(10). 1196–1200. 1 indexed citations

Iwashima, Yoshio, et al.. (2024). Clinical Benefit of Sacubitril/Valsartan for Hypertensive Patients in Daily Practice and Predictors of Its Antihypertensive Effect. Circulation Reports. 6(7). 248–254.

Iwashima, Yoshio, et al.. (2024). Serum uric acid-lowering effect of sacubitril/valsartan in hypertensive patients: evaluation by switching from angiotensin II receptor blockers. Blood Pressure Monitoring. 29(6). 305–311. 1 indexed citations

Iwashima, Yoshio, et al.. (2023). Efficacy and safety of sacubitril/valsartan after switching from azilsartan in hemodialysis patients with hypertension. Journal of Clinical Hypertension. 25(3). 304–308. 6 indexed citations

Iwashima, Yoshio & Toshihiko Ishimitsu. (2020). How should we define appropriate patients for percutaneous transluminal renal angioplasty treatment?. Hypertension Research. 43(10). 1015–1027. 9 indexed citations

Kokubo, Yoshihiro, Sandosh Padmanabhan, Yoshio Iwashima, Kazumasa Yamagishi, & Atsushi Goto. (2019). Gene and environmental interactions according to the components of lifestyle modifications in hypertension guidelines. Environmental Health and Preventive Medicine. 24(1). 19–19. 32 indexed citations

Horio, T., Maki Akiyama, Yoshio Iwashima, et al.. (2016). Preventive effect of renin-angiotensin system inhibitors on new-onset atrial fibrillation in hypertensive patients: a propensity score matching analysis. Journal of Human Hypertension. 31(7). 450–456. 3 indexed citations

Iwashima, Yoshio, Tetsuya Fukuda, Fumiki Yoshihara, et al.. (2016). Incidence and risk factors for restenosis, and its impact on blood pressure control after percutaneous transluminal renal angioplasty in hypertensive patients with renal artery stenosis. Journal of Hypertension. 34(7). 1407–1415. 17 indexed citations

Ohta, Yuko, Yoshio Iwashima, Shinichiro Hayashi, et al.. (2014). Trend of office and home blood pressure control in treated hypertensive patients: changes in antihypertensive medication and salt intake. Clinical and Experimental Hypertension. 36(2). 103–107. 4 indexed citations

10.

Akter, Shamima, Subrina Jesmin, Yoshio Iwashima, et al.. (2014). Higher circulatory level of endothelin-1 in hypertensive subjects screened through a cross-sectional study of rural Bangladeshi women. Hypertension Research. 38(3). 208–212. 17 indexed citations

11.

Yamasaki, Tomohiro, Yoshio Iwashima, Subrina Jesmin, et al.. (2014). Comparison of Efficacy of Intensive versus Mild Pitavastatin Therapy on Lipid and Inflammation Biomarkers in Hypertensive Patients with Dyslipidemia. PLoS ONE. 9(2). e89057–e89057. 5 indexed citations

12.

Doi, Yohei, Yoshio Iwashima, Fumiki Yoshihara, et al.. (2012). Renal Resistive Index and Cardiovascular and Renal Outcomes in Essential Hypertension. Hypertension. 60(3). 770–777. 91 indexed citations

13.

Kawano, Yuhei, Takeshi Horio, Kei Kamide, et al.. (2010). Blood Pressure and Medication During Long-Term Antihypertensive Therapy Based on Morning Home SBP in Hypertensive Patients: Hypertension Control Based On Home Systolic Pressure (HOSP) Substudy. Clinical and Experimental Hypertension. 32(4). 239–243. 2 indexed citations

14.

Horio, Takeshi, Yoshio Iwashima, Kei Kamide, et al.. (2010). Chronic kidney disease as an independent risk factor for new-onset atrial fibrillation in hypertensive patients. Journal of Hypertension. 28(8). 1738–1744. 95 indexed citations

15.

Iwashima, Yoshio, Takeshi Horio, Kei Kamide, et al.. (2008). Pulmonary venous flow and risk of cardiovascular disease in essential hypertension. Journal of Hypertension. 26(4). 798–805. 11 indexed citations

16.

Matsuo, Akiko, Tomohiro Katsuya, Kazuhiko Ishikawa, et al.. (2004). G2736A polymorphism of thiazide-sensitive Na-Cl cotransporter gene predisposes to hypertension in young women. Journal of Hypertension. 22(11). 2123–2127. 19 indexed citations

17.

Motone, Masaharu, Tomohiro Katsuya, Kazuhiko Ishikawa, et al.. (2004). Association between Hepatocyte Growth Factor Gene Polymorphism and Essential Hypertension. Hypertension Research. 27(4). 247–251. 14 indexed citations

18.

Iwashima, Yoshio, Takeshi Horio, Setsuko Kuroda, Shuichi Takishita, & Yuhei Kawano. (2002). Influence of Plasma Aldosterone on Left Ventricular Geometry and Diastolic Function in Treated Essential Hypertension. Hypertension Research. 25(1). 49–56. 34 indexed citations

19.

Katsuya, Tomohiro, Yoshio Iwashima, Ken Sugimoto, et al.. (2001). Effects of Antihypertensive Drugs and Gene Variants in the Renin-Angiotensin System.. Hypertension Research. 24(4). 463–467. 19 indexed citations

20.

Fu, Yuxiao, Tomohiro Katsuya, Takashi Asai, et al.. (2001). Lack of Correlation between Mbo I Restriction Fragment Length Polymorphism of Renin Gene and Essential Hypertension in Japanese.. Hypertension Research. 24(3). 295–298. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact